Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma cholesteryl ester transfer protein.

× No keyword cloud information.

182 in total

Review 1. Postprandial lipemia and coronary risk.

Authors: W Patsch; H Esterbauer; B Föger; J R Patsch
Journal: Curr Atheroscler Rep Date: 2000-05 Impact factor: 5.113

2. The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors: Richard E Morton; Yan Liu
Journal: J Lipid Res Date: 2020-06-26 Impact factor: 5.922

3. Effect of the nonenzymatic glycosylation of high density lipoprotein-3 on the cholesterol ester transfer protein activity.

Authors: B Lemkadem; D Loiseau; G Larcher; Y Malthiery; F Foussard
Journal: Lipids Date: 1999-12 Impact factor: 1.880

Review 4. New targets for medical treatment of lipid disorders.

Authors: Margaret E Brousseau; Ernst J Schaefer
Journal: Curr Atheroscler Rep Date: 2002-09 Impact factor: 5.113

5. Automated detection of informative combined effects in genetic association studies of complex traits.

Authors: Nadia Tahri-Daizadeh; David-Alexandre Tregouet; Viviane Nicaud; Nicolas Manuel; François Cambien; Laurence Tiret
Journal: Genome Res Date: 2003-08 Impact factor: 9.043

6. Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib.

Authors: Ronald M Krauss; Kathleen Wojnooski; Joseph Orr; J Casey Geaney; Cathy Anne Pinto; Yang Liu; John A Wagner; Julie Mabalot Luk; Amy O Johnson-Levonas; Matt S Anderson; Hayes M Dansky
Journal: J Lipid Res Date: 2011-12-17 Impact factor: 5.922

7. The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease.

Authors: Lei Yu; Joshua M Shulman; Lori Chibnik; Sue Leurgans; Julie A Schneider; Philip L De Jager; David A Bennett
Journal: Aging Cell Date: 2011-12-29 Impact factor: 9.304

8. Cardiovascular risk reduction via increasing HDL cholesterol: the promise of the dal-OUTCOMES Trial.

Authors: Kyaw Soe; Anis Alam; Charles Philip; Edison Ruiz; Keshwar Ramkissoon; Samy I McFarlane
Journal: Curr Diab Rep Date: 2011-02 Impact factor: 4.810

9. Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production.

Authors: Menno Hoekstra; Dan Ye; Reeni B Hildebrand; Ying Zhao; Bart Lammers; Miranda Stitzinger; Johan Kuiper; Theo J C Van Berkel; Miranda Van Eck
Journal: J Lipid Res Date: 2009-01-28 Impact factor: 5.922

10. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

Authors: A Inazu; X C Jiang; T Haraki; K Yagi; N Kamon; J Koizumi; H Mabuchi; R Takeda; K Takata; Y Moriyama
Journal: J Clin Invest Date: 1994-11 Impact factor: 14.808